The global Non-opioid Pain Patch market was valued at US$ 631.4 million in 2023 and is anticipated to reach US$ 779.5 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.

Non-opioid Pain Patch Market

A non-opioid pain patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

North American market for Non-opioid Pain Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Non-opioid Pain Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Non-opioid Pain Patch include Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis and Qizheng, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Non-opioid Pain Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-opioid Pain Patch.

Report Scope

The Non-opioid Pain Patch market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-opioid Pain Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-opioid Pain Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-opioid Pain Patch Market Report

Report Metric	Details
Report Name	Non-opioid Pain Patch Market
Accounted market size in 2023	US$ 631.4 million
Forecasted market size in 2030	US$ 779.5 million
CAGR	2.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Lidocaine Patches Diclofenac Patches Indomethacin Patches Counter-Irritant Patches Fentanyl Patches Others
Segment by Application	OTC Rx
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis, Qizheng, Endo, Huarun 999, GSK, Haw Par, Nichiban, Mentholatum, Laboratoires Genevrier, BLUE-EMU
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-opioid Pain Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-opioid Pain Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Non-opioid Pain Patch Market growing?

Ans: The Non-opioid Pain Patch Market witnessing a CAGR of 2.6% during the forecast period 2024-2030.

What is the Non-opioid Pain Patch Market size in 2030?

Ans: The Non-opioid Pain Patch Market size in 2030 will be US$ 779.5 million.

Who are the main players in the Non-opioid Pain Patch Market report?

Ans: The main players in the Non-opioid Pain Patch Market are Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis, Qizheng, Endo, Huarun 999, GSK, Haw Par, Nichiban, Mentholatum, Laboratoires Genevrier, BLUE-EMU

What are the Application segmentation covered in the Non-opioid Pain Patch Market report?

Ans: The Applications covered in the Non-opioid Pain Patch Market report are OTC, Rx

What are the Type segmentation covered in the Non-opioid Pain Patch Market report?

Ans: The Types covered in the Non-opioid Pain Patch Market report are Lidocaine Patches, Diclofenac Patches, Indomethacin Patches, Counter-Irritant Patches, Fentanyl Patches, Others

1 Non-opioid Pain Patch Market Overview

1.1 Product Overview and Scope of Non-opioid Pain Patch

1.2 Non-opioid Pain Patch Segment by Type

1.2.1 Global Non-opioid Pain Patch Market Value Comparison by Type (2024-2030)

1.2.2 Lidocaine Patches

1.2.3 Diclofenac Patches

1.2.4 Indomethacin Patches

1.2.5 Counter-Irritant Patches

1.2.6 Fentanyl Patches

1.2.7 Others

1.3 Non-opioid Pain Patch Segment by Application

1.3.1 Global Non-opioid Pain Patch Market Value by Application: (2024-2030)

1.3.2 OTC

1.3.3 Rx

1.4 Global Non-opioid Pain Patch Market Size Estimates and Forecasts

1.4.1 Global Non-opioid Pain Patch Revenue 2019-2030

1.4.2 Global Non-opioid Pain Patch Sales 2019-2030

1.4.3 Global Non-opioid Pain Patch Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Non-opioid Pain Patch Market Competition by Manufacturers

2.1 Global Non-opioid Pain Patch Sales Market Share by Manufacturers (2019-2024)

2.2 Global Non-opioid Pain Patch Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Non-opioid Pain Patch Average Price by Manufacturers (2019-2024)

2.4 Global Non-opioid Pain Patch Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Non-opioid Pain Patch, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Non-opioid Pain Patch, Product Type & Application

2.7 Non-opioid Pain Patch Market Competitive Situation and Trends

2.7.1 Non-opioid Pain Patch Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Non-opioid Pain Patch Players Market Share by Revenue

2.7.3 Global Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Non-opioid Pain Patch Retrospective Market Scenario by Region

3.1 Global Non-opioid Pain Patch Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Non-opioid Pain Patch Global Non-opioid Pain Patch Sales by Region: 2019-2030

3.2.1 Global Non-opioid Pain Patch Sales by Region: 2019-2024

3.2.2 Global Non-opioid Pain Patch Sales by Region: 2025-2030

3.3 Global Non-opioid Pain Patch Global Non-opioid Pain Patch Revenue by Region: 2019-2030

3.3.1 Global Non-opioid Pain Patch Revenue by Region: 2019-2024

3.3.2 Global Non-opioid Pain Patch Revenue by Region: 2025-2030

3.4 North America Non-opioid Pain Patch Market Facts & Figures by Country

3.4.1 North America Non-opioid Pain Patch Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Non-opioid Pain Patch Sales by Country (2019-2030)

3.4.3 North America Non-opioid Pain Patch Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Non-opioid Pain Patch Market Facts & Figures by Country

3.5.1 Europe Non-opioid Pain Patch Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Non-opioid Pain Patch Sales by Country (2019-2030)

3.5.3 Europe Non-opioid Pain Patch Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Non-opioid Pain Patch Market Facts & Figures by Country

3.6.1 Asia Pacific Non-opioid Pain Patch Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Non-opioid Pain Patch Sales by Country (2019-2030)

3.6.3 Asia Pacific Non-opioid Pain Patch Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Non-opioid Pain Patch Market Facts & Figures by Country

3.7.1 Latin America Non-opioid Pain Patch Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Non-opioid Pain Patch Sales by Country (2019-2030)

3.7.3 Latin America Non-opioid Pain Patch Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Non-opioid Pain Patch Market Facts & Figures by Country

3.8.1 Middle East and Africa Non-opioid Pain Patch Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Non-opioid Pain Patch Sales by Country (2019-2030)

3.8.3 Middle East and Africa Non-opioid Pain Patch Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Non-opioid Pain Patch Sales by Type (2019-2030)

4.1.1 Global Non-opioid Pain Patch Sales by Type (2019-2024)

4.1.2 Global Non-opioid Pain Patch Sales by Type (2025-2030)

4.1.3 Global Non-opioid Pain Patch Sales Market Share by Type (2019-2030)

4.2 Global Non-opioid Pain Patch Revenue by Type (2019-2030)

4.2.1 Global Non-opioid Pain Patch Revenue by Type (2019-2024)

4.2.2 Global Non-opioid Pain Patch Revenue by Type (2025-2030)

4.2.3 Global Non-opioid Pain Patch Revenue Market Share by Type (2019-2030)

4.3 Global Non-opioid Pain Patch Price by Type (2019-2030)

5 Segment by Application

5.1 Global Non-opioid Pain Patch Sales by Application (2019-2030)

5.1.1 Global Non-opioid Pain Patch Sales by Application (2019-2024)

5.1.2 Global Non-opioid Pain Patch Sales by Application (2025-2030)

5.1.3 Global Non-opioid Pain Patch Sales Market Share by Application (2019-2030)

5.2 Global Non-opioid Pain Patch Revenue by Application (2019-2030)

5.2.1 Global Non-opioid Pain Patch Revenue by Application (2019-2024)

5.2.2 Global Non-opioid Pain Patch Revenue by Application (2025-2030)

5.2.3 Global Non-opioid Pain Patch Revenue Market Share by Application (2019-2030)

5.3 Global Non-opioid Pain Patch Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Hisamitsu

6.1.1 Hisamitsu Corporation Information

6.1.2 Hisamitsu Description and Business Overview

6.1.3 Hisamitsu Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Hisamitsu Non-opioid Pain Patch Product Portfolio

6.1.5 Hisamitsu Recent Developments/Updates

6.2 Mylan

6.2.1 Mylan Corporation Information

6.2.2 Mylan Description and Business Overview

6.2.3 Mylan Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Mylan Non-opioid Pain Patch Product Portfolio

6.2.5 Mylan Recent Developments/Updates

6.3 Johnson & Johnson

6.3.1 Johnson & Johnson Corporation Information

6.3.2 Johnson & Johnson Description and Business Overview

6.3.3 Johnson & Johnson Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Johnson & Johnson Non-opioid Pain Patch Product Portfolio

6.3.5 Johnson & Johnson Recent Developments/Updates

6.4 Actavis

6.4.1 Actavis Corporation Information

6.4.2 Actavis Description and Business Overview

6.4.3 Actavis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Actavis Non-opioid Pain Patch Product Portfolio

6.4.5 Actavis Recent Developments/Updates

6.5 Lingrui

6.5.1 Lingrui Corporation Information

6.5.2 Lingrui Description and Business Overview

6.5.3 Lingrui Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Lingrui Non-opioid Pain Patch Product Portfolio

6.5.5 Lingrui Recent Developments/Updates

6.6 Teikoku Seiyaku

6.6.1 Teikoku Seiyaku Corporation Information

6.6.2 Teikoku Seiyaku Description and Business Overview

6.6.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Teikoku Seiyaku Non-opioid Pain Patch Product Portfolio

6.6.5 Teikoku Seiyaku Recent Developments/Updates

6.7 Sanofi

6.6.1 Sanofi Corporation Information

6.6.2 Sanofi Description and Business Overview

6.6.3 Sanofi Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sanofi Non-opioid Pain Patch Product Portfolio

6.7.5 Sanofi Recent Developments/Updates

6.8 Novartis

6.8.1 Novartis Corporation Information

6.8.2 Novartis Description and Business Overview

6.8.3 Novartis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Novartis Non-opioid Pain Patch Product Portfolio

6.8.5 Novartis Recent Developments/Updates

6.9 Qizheng

6.9.1 Qizheng Corporation Information

6.9.2 Qizheng Description and Business Overview

6.9.3 Qizheng Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Qizheng Non-opioid Pain Patch Product Portfolio

6.9.5 Qizheng Recent Developments/Updates

6.10 Endo

6.10.1 Endo Corporation Information

6.10.2 Endo Description and Business Overview

6.10.3 Endo Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Endo Non-opioid Pain Patch Product Portfolio

6.10.5 Endo Recent Developments/Updates

6.11 Huarun 999

6.11.1 Huarun 999 Corporation Information

6.11.2 Huarun 999 Non-opioid Pain Patch Description and Business Overview

6.11.3 Huarun 999 Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Huarun 999 Non-opioid Pain Patch Product Portfolio

6.11.5 Huarun 999 Recent Developments/Updates

6.12 GSK

6.12.1 GSK Corporation Information

6.12.2 GSK Non-opioid Pain Patch Description and Business Overview

6.12.3 GSK Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.12.4 GSK Non-opioid Pain Patch Product Portfolio

6.12.5 GSK Recent Developments/Updates

6.13 Haw Par

6.13.1 Haw Par Corporation Information

6.13.2 Haw Par Non-opioid Pain Patch Description and Business Overview

6.13.3 Haw Par Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Haw Par Non-opioid Pain Patch Product Portfolio

6.13.5 Haw Par Recent Developments/Updates

6.14 Nichiban

6.14.1 Nichiban Corporation Information

6.14.2 Nichiban Non-opioid Pain Patch Description and Business Overview

6.14.3 Nichiban Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Nichiban Non-opioid Pain Patch Product Portfolio

6.14.5 Nichiban Recent Developments/Updates

6.15 Mentholatum

6.15.1 Mentholatum Corporation Information

6.15.2 Mentholatum Non-opioid Pain Patch Description and Business Overview

6.15.3 Mentholatum Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Mentholatum Non-opioid Pain Patch Product Portfolio

6.15.5 Mentholatum Recent Developments/Updates

6.16 Laboratoires Genevrier

6.16.1 Laboratoires Genevrier Corporation Information

6.16.2 Laboratoires Genevrier Non-opioid Pain Patch Description and Business Overview

6.16.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Laboratoires Genevrier Non-opioid Pain Patch Product Portfolio

6.16.5 Laboratoires Genevrier Recent Developments/Updates

6.17 BLUE-EMU

6.17.1 BLUE-EMU Corporation Information

6.17.2 BLUE-EMU Non-opioid Pain Patch Description and Business Overview

6.17.3 BLUE-EMU Non-opioid Pain Patch Sales, Revenue and Gross Margin (2019-2024)

6.17.4 BLUE-EMU Non-opioid Pain Patch Product Portfolio

6.17.5 BLUE-EMU Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Non-opioid Pain Patch Industry Chain Analysis

7.2 Non-opioid Pain Patch Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Non-opioid Pain Patch Production Mode & Process

7.4 Non-opioid Pain Patch Sales and Marketing

7.4.1 Non-opioid Pain Patch Sales Channels

7.4.2 Non-opioid Pain Patch Distributors

7.5 Non-opioid Pain Patch Customers

8 Non-opioid Pain Patch Market Dynamics

8.1 Non-opioid Pain Patch Industry Trends

8.2 Non-opioid Pain Patch Market Drivers

8.3 Non-opioid Pain Patch Market Challenges

8.4 Non-opioid Pain Patch Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Laboratoires Genevrier

BLUE-EMU

List of Tables

Table 1. Global Non-opioid Pain Patch Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Non-opioid Pain Patch Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Non-opioid Pain Patch Market Competitive Situation by Manufacturers in 2023

Table 4. Global Non-opioid Pain Patch Sales (M Units) of Key Manufacturers (2019-2024)

Table 5. Global Non-opioid Pain Patch Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Non-opioid Pain Patch Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Non-opioid Pain Patch Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Non-opioid Pain Patch Average Price (USD/K Units) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Non-opioid Pain Patch, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Non-opioid Pain Patch, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Non-opioid Pain Patch, Product Type & Application

Table 12. Global Key Manufacturers of Non-opioid Pain Patch, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Non-opioid Pain Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Pain Patch as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Non-opioid Pain Patch Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Non-opioid Pain Patch Sales by Region (2019-2024) & (M Units)

Table 18. Global Non-opioid Pain Patch Sales Market Share by Region (2019-2024)

Table 19. Global Non-opioid Pain Patch Sales by Region (2025-2030) & (M Units)

Table 20. Global Non-opioid Pain Patch Sales Market Share by Region (2025-2030)

Table 21. Global Non-opioid Pain Patch Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Non-opioid Pain Patch Revenue Market Share by Region (2019-2024)

Table 23. Global Non-opioid Pain Patch Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Non-opioid Pain Patch Revenue Market Share by Region (2025-2030)

Table 25. North America Non-opioid Pain Patch Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Non-opioid Pain Patch Sales by Country (2019-2024) & (M Units)

Table 27. North America Non-opioid Pain Patch Sales by Country (2025-2030) & (M Units)

Table 28. North America Non-opioid Pain Patch Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Non-opioid Pain Patch Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Non-opioid Pain Patch Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Non-opioid Pain Patch Sales by Country (2019-2024) & (M Units)

Table 32. Europe Non-opioid Pain Patch Sales by Country (2025-2030) & (M Units)

Table 33. Europe Non-opioid Pain Patch Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Non-opioid Pain Patch Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Non-opioid Pain Patch Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Non-opioid Pain Patch Sales by Region (2019-2024) & (M Units)

Table 37. Asia Pacific Non-opioid Pain Patch Sales by Region (2025-2030) & (M Units)

Table 38. Asia Pacific Non-opioid Pain Patch Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Non-opioid Pain Patch Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Non-opioid Pain Patch Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Non-opioid Pain Patch Sales by Country (2019-2024) & (M Units)

Table 42. Latin America Non-opioid Pain Patch Sales by Country (2025-2030) & (M Units)

Table 43. Latin America Non-opioid Pain Patch Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Non-opioid Pain Patch Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Non-opioid Pain Patch Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Non-opioid Pain Patch Sales by Country (2019-2024) & (M Units)

Table 47. Middle East & Africa Non-opioid Pain Patch Sales by Country (2025-2030) & (M Units)

Table 48. Middle East & Africa Non-opioid Pain Patch Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Non-opioid Pain Patch Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Non-opioid Pain Patch Sales (M Units) by Type (2019-2024)

Table 51. Global Non-opioid Pain Patch Sales (M Units) by Type (2025-2030)

Table 52. Global Non-opioid Pain Patch Sales Market Share by Type (2019-2024)

Table 53. Global Non-opioid Pain Patch Sales Market Share by Type (2025-2030)

Table 54. Global Non-opioid Pain Patch Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Non-opioid Pain Patch Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Non-opioid Pain Patch Revenue Market Share by Type (2019-2024)

Table 57. Global Non-opioid Pain Patch Revenue Market Share by Type (2025-2030)

Table 58. Global Non-opioid Pain Patch Price (USD/K Units) by Type (2019-2024)

Table 59. Global Non-opioid Pain Patch Price (USD/K Units) by Type (2025-2030)

Table 60. Global Non-opioid Pain Patch Sales (M Units) by Application (2019-2024)

Table 61. Global Non-opioid Pain Patch Sales (M Units) by Application (2025-2030)

Table 62. Global Non-opioid Pain Patch Sales Market Share by Application (2019-2024)

Table 63. Global Non-opioid Pain Patch Sales Market Share by Application (2025-2030)

Table 64. Global Non-opioid Pain Patch Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Non-opioid Pain Patch Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Non-opioid Pain Patch Revenue Market Share by Application (2019-2024)

Table 67. Global Non-opioid Pain Patch Revenue Market Share by Application (2025-2030)

Table 68. Global Non-opioid Pain Patch Price (USD/K Units) by Application (2019-2024)

Table 69. Global Non-opioid Pain Patch Price (USD/K Units) by Application (2025-2030)

Table 70. Hisamitsu Corporation Information

Table 71. Hisamitsu Description and Business Overview

Table 72. Hisamitsu Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 73. Hisamitsu Non-opioid Pain Patch Product

Table 74. Hisamitsu Recent Developments/Updates

Table 75. Mylan Corporation Information

Table 76. Mylan Description and Business Overview

Table 77. Mylan Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 78. Mylan Non-opioid Pain Patch Product

Table 79. Mylan Recent Developments/Updates

Table 80. Johnson & Johnson Corporation Information

Table 81. Johnson & Johnson Description and Business Overview

Table 82. Johnson & Johnson Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 83. Johnson & Johnson Non-opioid Pain Patch Product

Table 84. Johnson & Johnson Recent Developments/Updates

Table 85. Actavis Corporation Information

Table 86. Actavis Description and Business Overview

Table 87. Actavis Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 88. Actavis Non-opioid Pain Patch Product

Table 89. Actavis Recent Developments/Updates

Table 90. Lingrui Corporation Information

Table 91. Lingrui Description and Business Overview

Table 92. Lingrui Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 93. Lingrui Non-opioid Pain Patch Product

Table 94. Lingrui Recent Developments/Updates

Table 95. Teikoku Seiyaku Corporation Information

Table 96. Teikoku Seiyaku Description and Business Overview

Table 97. Teikoku Seiyaku Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 98. Teikoku Seiyaku Non-opioid Pain Patch Product

Table 99. Teikoku Seiyaku Recent Developments/Updates

Table 100. Sanofi Corporation Information

Table 101. Sanofi Description and Business Overview

Table 102. Sanofi Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 103. Sanofi Non-opioid Pain Patch Product

Table 104. Sanofi Recent Developments/Updates

Table 105. Novartis Corporation Information

Table 106. Novartis Description and Business Overview

Table 107. Novartis Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 108. Novartis Non-opioid Pain Patch Product

Table 109. Novartis Recent Developments/Updates

Table 110. Qizheng Corporation Information

Table 111. Qizheng Description and Business Overview

Table 112. Qizheng Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 113. Qizheng Non-opioid Pain Patch Product

Table 114. Qizheng Recent Developments/Updates

Table 115. Endo Corporation Information

Table 116. Endo Description and Business Overview

Table 117. Endo Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 118. Endo Non-opioid Pain Patch Product

Table 119. Endo Recent Developments/Updates

Table 120. Huarun 999 Corporation Information

Table 121. Huarun 999 Description and Business Overview

Table 122. Huarun 999 Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 123. Huarun 999 Non-opioid Pain Patch Product

Table 124. Huarun 999 Recent Developments/Updates

Table 125. GSK Corporation Information

Table 126. GSK Description and Business Overview

Table 127. GSK Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 128. GSK Non-opioid Pain Patch Product

Table 129. GSK Recent Developments/Updates

Table 130. Haw Par Corporation Information

Table 131. Haw Par Description and Business Overview

Table 132. Haw Par Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 133. Haw Par Non-opioid Pain Patch Product

Table 134. Haw Par Recent Developments/Updates

Table 135. Nichiban Corporation Information

Table 136. Nichiban Description and Business Overview

Table 137. Nichiban Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 138. Nichiban Non-opioid Pain Patch Product

Table 139. Nichiban Recent Developments/Updates

Table 140. Mentholatum Corporation Information

Table 141. Mentholatum Description and Business Overview

Table 142. Mentholatum Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 143. Mentholatum Non-opioid Pain Patch Product

Table 144. Mentholatum Recent Developments/Updates

Table 145. Laboratoires Genevrier Corporation Information

Table 146. Laboratoires Genevrier Description and Business Overview

Table 147. Laboratoires Genevrier Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 148. Laboratoires Genevrier Non-opioid Pain Patch Product

Table 149. Laboratoires Genevrier Recent Developments/Updates

Table 150. BLUE-EMU Corporation Information

Table 151. BLUE-EMU Description and Business Overview

Table 152. BLUE-EMU Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 153. BLUE-EMU Non-opioid Pain Patch Product

Table 154. BLUE-EMU Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Non-opioid Pain Patch Distributors List

Table 158. Non-opioid Pain Patch Customers List

Table 159. Non-opioid Pain Patch Market Trends

Table 160. Non-opioid Pain Patch Market Drivers

Table 161. Non-opioid Pain Patch Market Challenges

Table 162. Non-opioid Pain Patch Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Non-opioid Pain Patch

Figure 2. Global Non-opioid Pain Patch Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Non-opioid Pain Patch Market Share by Type in 2023 & 2030

Figure 4. Lidocaine Patches Product Picture

Figure 5. Diclofenac Patches Product Picture

Figure 6. Indomethacin Patches Product Picture

Figure 7. Counter-Irritant Patches Product Picture

Figure 8. Fentanyl Patches Product Picture

Figure 9. Others Product Picture

Figure 10. Global Non-opioid Pain Patch Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Non-opioid Pain Patch Market Share by Application in 2023 & 2030

Figure 12. OTC

Figure 13. Rx

Figure 14. Global Non-opioid Pain Patch Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Non-opioid Pain Patch Market Size (2019-2030) & (US$ Million)

Figure 16. Global Non-opioid Pain Patch Sales (2019-2030) & (M Units)

Figure 17. Global Non-opioid Pain Patch Average Price (USD/K Units) & (2019-2030)

Figure 18. Non-opioid Pain Patch Report Years Considered

Figure 19. Non-opioid Pain Patch Sales Share by Manufacturers in 2023

Figure 20. Global Non-opioid Pain Patch Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Non-opioid Pain Patch Players: Market Share by Revenue in 2023

Figure 22. Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Non-opioid Pain Patch Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Non-opioid Pain Patch Sales Market Share by Country (2019-2030)

Figure 25. North America Non-opioid Pain Patch Revenue Market Share by Country (2019-2030)

Figure 26. U.S. Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Non-opioid Pain Patch Sales Market Share by Country (2019-2030)

Figure 29. Europe Non-opioid Pain Patch Revenue Market Share by Country (2019-2030)

Figure 30. Germany Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Non-opioid Pain Patch Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Non-opioid Pain Patch Revenue Market Share by Region (2019-2030)

Figure 37. China Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Taiwan Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Indonesia Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Thailand Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Malaysia Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Philippines Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America Non-opioid Pain Patch Sales Market Share by Country (2019-2030)

Figure 48. Latin America Non-opioid Pain Patch Revenue Market Share by Country (2019-2030)

Figure 49. Mexico Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Non-opioid Pain Patch Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa Non-opioid Pain Patch Revenue Market Share by Country (2019-2030)

Figure 54. Turkey Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. UAE Non-opioid Pain Patch Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of Non-opioid Pain Patch by Type (2019-2030)

Figure 58. Global Revenue Market Share of Non-opioid Pain Patch by Type (2019-2030)

Figure 59. Global Non-opioid Pain Patch Price (USD/K Units) by Type (2019-2030)

Figure 60. Global Sales Market Share of Non-opioid Pain Patch by Application (2019-2030)

Figure 61. Global Revenue Market Share of Non-opioid Pain Patch by Application (2019-2030)

Figure 62. Global Non-opioid Pain Patch Price (USD/K Units) by Application (2019-2030)

Figure 63. Non-opioid Pain Patch Value Chain

Figure 64. Non-opioid Pain Patch Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions